Monday 17 January 2022
- Advertisement -
spot_imgspot_img

SII seeks DCGI’s approval for Covishield as booster dose

The Serum Institute of India has sought approval for Covishield as a booster dose from India’s drug regulator, citing adequate stock of the in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said.

In an application to the Drugs Controller General of India (DCGI), Director of Government and Regulatory Affairs at Serum Institute of India (SII) Prakash Kumar Singh wrote that the UK’s Medicines and Healthcare products Regulatory Agency had already approved the booster dose of AstraZeneca ChAdOx1 nCoV-19 vaccine, they said.

Singh is learnt to have said in the application that as the world continues to face the pandemic situation, many countries have started administering a booster dose of Covid-19 vaccines.

“People of our country, as well as citizens of other countries who have already been fully vaccinated with two doses of Covishield, are continuously requesting our firm for booster dose,” an official source quoted Singh as having said in the application yesterday.

“You are aware that now there is no shortage of Covishield in our country and the demand for a booster dose is increasing day by day from the people who have already taken two doses in view of the ongoing Covid-19 pandemic and emergence of new strains.”

It is the need of the hour and a matter of right to health of every individual that they should not be deprived of third dose/booster dose to protect themselves in this pandemic situation, Singh stated.

The union government has informed the parliament that the National Technical Advisory Group on Immunization and National Expert Group on Administration for Covid-19 are deliberating and considering scientific evidence for the need and justification for a booster dose.

Recently, Kerala, Rajasthan, Karnataka and Chhattisgarh have urged the Centre to decide on allowing booster doses of Covid-19 diseased amid concerns raised by ‘Omicron’, the new variant of Sars-CoV-2.

The Delhi High Court on November 25 directed the union government to clarify its stand on administering booster doses to those who are fully vaccinated against coronavirus, saying it does not want a second-wave-like situation on account of being conservative.

Get in Touch

0 0 votes
Article Rating
Subscribe
Notify of

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments
spot_imgspot_img

Related Articles

Editorial

Get in Touch

7,493FansLike
2,454FollowersFollow
0SubscribersSubscribe

Columns

0
Would love your thoughts, please comment.x
()
x
[prisna-google-website-translator]
%d bloggers like this: